Sources | Names Used |
---|---|
CCLE, GDSC1000, GRAY | 17-AAG |
FIMM | Tanespimycin |
CTRPv2 | tanespimycin |
PharmacoGx | 17-AAG |
Database | Identifier |
---|---|
Smiles: | CC1CC(C(C(C=C(C(C(C=CC=C(C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)C)OC)OC(=O)N)C)C)O)OC |
Inchikey: | AYUNIORJHRXIBJ-TXHRRWQRSA-N |
Pubchem: | 6505803 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ACTN4 | GDSC1000 | pan-cancer | AAC | 0.17 | 7e-06 |
mRNA | ACVR1 | GDSC1000 | pan-cancer | AAC | 0.18 | 1e-06 |
mRNA | ACVR1B | GDSC1000 | pan-cancer | AAC | -0.14 | 3e-05 |
mRNA | ACVR2B | GDSC1000 | pan-cancer | AAC | -0.14 | 6e-05 |
mRNA | ADAM15 | GDSC1000 | pan-cancer | AAC | 0.16 | 1e-05 |
mRNA | ADAM9 | GDSC1000 | pan-cancer | AAC | 0.32 | 5e-14 |
mRNA | ADAMTS5 | CCLE | pan-cancer | AAC | -0.19 | 0.0001 |
mRNA | ADAMTS8 | CCLE | pan-cancer | AAC | -0.19 | 2e-05 |
mRNA | ADCY1 | GDSC1000 | pan-cancer | AAC | -0.16 | 2e-05 |
mRNA | ADGRB3 | GDSC1000 | pan-cancer | AAC | -0.17 | 4e-06 |